Copy number-based quantification assay for non-invasive detection of PVT1-derived transcripts.
BACKGROUND:One of the most important susceptibility loci for cancer is the 8q24 human chromosomal region. The non-protein coding gene locus plasmacytoma variant translocation 1 (PVT1) is located at 8q24 and is dysregulated in prostate cancer. PVT1 gives rise to multiple transcripts which may have di...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2019-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0226620 |
| _version_ | 1818590506836295680 |
|---|---|
| author | Gargi Pal Olorunseun O Ogunwobi |
| author_facet | Gargi Pal Olorunseun O Ogunwobi |
| author_sort | Gargi Pal |
| collection | DOAJ |
| description | BACKGROUND:One of the most important susceptibility loci for cancer is the 8q24 human chromosomal region. The non-protein coding gene locus plasmacytoma variant translocation 1 (PVT1) is located at 8q24 and is dysregulated in prostate cancer. PVT1 gives rise to multiple transcripts which may have different functions. Here, we describe a real-time quantitative polymerase chain reaction (qPCR)-based assay for copy number-based quantitation of PVT1 exons 4A, 4B, and 9 to enable accurate, reproducible, and quantifiable detection. METHODS:PVT1 exons 4A, 4B, and 9 were cloned into a plasmid vector to create standards for subsequent creation of linear standard curves representing a broad range of concentrations. PCR was carried out using SYBR-Green signal detection to quantify PVT1 exons 4A, 4B, and 9. The efficacy of this assay was evaluated by using it to detect these transcripts in prostate epithelial and prostate cancer cell lines, normal and cancerous human prostate tissues, human serum, mouse plasma, and urine samples. RESULTS:The results indicate that the assay can be used to quantify both low and high copy numbers of PVT1-derived transcripts. This is the first report of a copy number-based quantification assay for non-invasive detection of PVT1 derived transcripts. CONCLUSIONS:This novel assay holds promise for routine non-invasive testing in diseases where PVT1 is dysregulated. |
| first_indexed | 2024-12-16T09:57:38Z |
| format | Article |
| id | doaj.art-d1f41877882b47ab912e106c930aa709 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-16T09:57:38Z |
| publishDate | 2019-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-d1f41877882b47ab912e106c930aa7092022-12-21T22:35:53ZengPublic Library of Science (PLoS)PLoS ONE1932-62032019-01-011412e022662010.1371/journal.pone.0226620Copy number-based quantification assay for non-invasive detection of PVT1-derived transcripts.Gargi PalOlorunseun O OgunwobiBACKGROUND:One of the most important susceptibility loci for cancer is the 8q24 human chromosomal region. The non-protein coding gene locus plasmacytoma variant translocation 1 (PVT1) is located at 8q24 and is dysregulated in prostate cancer. PVT1 gives rise to multiple transcripts which may have different functions. Here, we describe a real-time quantitative polymerase chain reaction (qPCR)-based assay for copy number-based quantitation of PVT1 exons 4A, 4B, and 9 to enable accurate, reproducible, and quantifiable detection. METHODS:PVT1 exons 4A, 4B, and 9 were cloned into a plasmid vector to create standards for subsequent creation of linear standard curves representing a broad range of concentrations. PCR was carried out using SYBR-Green signal detection to quantify PVT1 exons 4A, 4B, and 9. The efficacy of this assay was evaluated by using it to detect these transcripts in prostate epithelial and prostate cancer cell lines, normal and cancerous human prostate tissues, human serum, mouse plasma, and urine samples. RESULTS:The results indicate that the assay can be used to quantify both low and high copy numbers of PVT1-derived transcripts. This is the first report of a copy number-based quantification assay for non-invasive detection of PVT1 derived transcripts. CONCLUSIONS:This novel assay holds promise for routine non-invasive testing in diseases where PVT1 is dysregulated.https://doi.org/10.1371/journal.pone.0226620 |
| spellingShingle | Gargi Pal Olorunseun O Ogunwobi Copy number-based quantification assay for non-invasive detection of PVT1-derived transcripts. PLoS ONE |
| title | Copy number-based quantification assay for non-invasive detection of PVT1-derived transcripts. |
| title_full | Copy number-based quantification assay for non-invasive detection of PVT1-derived transcripts. |
| title_fullStr | Copy number-based quantification assay for non-invasive detection of PVT1-derived transcripts. |
| title_full_unstemmed | Copy number-based quantification assay for non-invasive detection of PVT1-derived transcripts. |
| title_short | Copy number-based quantification assay for non-invasive detection of PVT1-derived transcripts. |
| title_sort | copy number based quantification assay for non invasive detection of pvt1 derived transcripts |
| url | https://doi.org/10.1371/journal.pone.0226620 |
| work_keys_str_mv | AT gargipal copynumberbasedquantificationassayfornoninvasivedetectionofpvt1derivedtranscripts AT olorunseunoogunwobi copynumberbasedquantificationassayfornoninvasivedetectionofpvt1derivedtranscripts |